The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms

Open Cardiovascular Medicine Journal

Volumn 3, Issue , 2009, Pages 48-50

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Mikhailidis, Dimitri P ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TORCETRAPIB;

ALLELE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; GENETIC ASSOCIATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; NONHUMAN; NOTE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC ANIMAL; UNSPECIFIED SIDE EFFECT;

EID: 77952700057     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192400903010048     Document Type: Note

References (45)

1. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res 2004; 45: 1967-1974 (Pubitemid 40990890)
2. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389 (Pubitemid 24365311)
4. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001-1009
5. Gotto AM Jr. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation 2001; 103: 2213-2218 (Pubitemid 32458332)
6. de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, et al. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 2002; 105: 2159-2165 (Pubitemid 34517159)
7. Brousseau ME, Schaefer EJ, Wolfe ML, et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 2004; 350: 1505-1515 (Pubitemid 38477775)
8. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 2004; 24: 490-497 (Pubitemid 38326143)
9. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Castro Cabezas M. Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 2008; 9: 39-44.
10. Kapoor JR. Postprandial triglyceride levels and cardiovascular risk. Am Fam Physician 2008; 77: 1504.
11. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485
12. Kolovou GD, Daskalova DCh, Iraklianou SA, et al. Postprandial lipemia in hypertension. J Am Coll Nutr 2003; 22: 80-87
13. Kolovou G, Daskalova D, Anagnostopoulou K, et al. Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol 2003; 56: 937-941 (Pubitemid 37533238)
14. Kolovou GD, Anagnostopoulou KK, Pilatis ND, et al. Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia. Int J Clin Pract 2005; 59: 311-317 (Pubitemid 40352748)
15. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, et al. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005; 4: 21. (Pubitemid 41584026)
16. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308. (Pubitemid 47080484)
17. Granér M, Kahri J, Nakano T, et al. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease. Eur J Clin Invest 2006; 36: 764-770 (Pubitemid 44569964)
18. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005; 12: 1931-1945
19. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000; 20: 1323-1329 (Pubitemid 30262934)
20. Li TY, Zhang C, Asselbergs FW, et al. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men. Am J Clin Nutr 2007; 86: 1524-1529 (Pubitemid 350126260)
21. Volcik K, Ballantyne CM, Pownall HJ, Sharrett AR, Boerwinkle E. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study. J Stud Alcohol Drugs 2007; 68: 485-492 (Pubitemid 47092975)
22. Goldenberg I, Moss AJ, Block R, et al. Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers. Ann Noninvasive Electrocardiol 2007; 12: 364-374 (Pubitemid 350013259)
23. Alssema M, Dekker JM, Kuivenhoven JA, et al. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study. Diabet Med 2007; 24: 117-123 (Pubitemid 46174933)
24. Thompson A, Di Angelantonio E, Sarwar N, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008; 299: 2777-2788 (Pubitemid 351846853)
25. Tsai MY, Johnson C, Kao WH, et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008; 200: 359-367
26. Kolovou GD, Anagnostopoulou KK, Karyofillis P, et al. Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis. Clin Invest Med 2006; 29: 14-19
27. Salerno A, Patrício P, Berti J, Oliveira H. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridemia and delays triglyceride plasma clearance in transgenic mice. Biochem J 2009; 419: 629-634
28. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 364: 73-75 (Pubitemid 23233459)
29. Gudnason V, Kakko S, Nicaud V, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999; 29: 116-128 (Pubitemid 29090250)
30. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990; 2: 1372-1376 (Pubitemid 20063363)
31. Kuivenhoven JA, de Knijff P, Boer JM, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997; 17: 560-568
32. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101: 1907-1912 (Pubitemid 30225270)
33. Corella D, Sáiz C, Guillén M, et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 2000; 152: 367-376 (Pubitemid 30686324)
34. Kapur NK, Ashen D, Blumenthal RS. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag 2008; 4: 39-57.
35. Kolovou G, Anagnostopoulou K, Kostakou P, et al. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia. Clin Chem Lab Med 2007; 45: 1190-1198 (Pubitemid 47396278)
36. Noone E, Roche HM, Black I, Tully AM, Gibney MJ. Effect of postprandial lipaemia and Taq 1B polymorphism of the cholesteryl ester transfer protein (CETP) gene on CETP mass, activity, associated lipoproteins and plasma lipids. Br J Nutr 2000; 84: 203-209 (Pubitemid 30670248)
37. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem 1995; 64: 235-257
38. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998; 338: 86-93.
39. Thu NN, Mai TT, Ohmori R, et al. Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children. Pediatr Res 2005; 58: 1249-1253 (Pubitemid 43755707)
40. Hogue JC, Lamarche B, Gaudet D, et al. Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia. J Lipid Res 2004; 45: 1077-1083 (Pubitemid 38679503)
41. Anagnostopoulou KK, Kolovou GD, Kostakou PM, et al. Sexassociated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia. Lipids Health Dis 2009 (in press).
42. Zhou H, Li Z, Hojjati MR, et al. Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. J Lipid Res 2006; 47: 2011-2019 (Pubitemid 44401989)
43. Ye SQ, Kwiterovich PO Jr. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 2000; 72: 1275-1284 (Pubitemid 30824219)
44. Inazu A, Nakajima K, Nakano T, et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclerosis 2008; 196: 953-957
45. Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008; 19: 355-361